Dr. Dennis Vriens (LUMC)
This short overview will cover some basic nuclear physics and provide a glimpse of newest technological developments (quantitative SPECT, full body PET/CT, PET/MR, reconstruction, image analysis) and tracer developments. Afterwards you know what near future awaits and what lies beyond the horizon of oncological nuclear medicine.

Dr. Jan-Willem M. Beenakker (LUMC)
Developments in MRI for oncology aim to achieve better differentiation between tumor types, more accurate tumour delineation and more sensitive follow-up post radiotherapy. In this talk the benefits of novel MR-technologies will be explained in the context of intra-ocular tumors. In addition, the challenges that emerge when a new imaging modality is introduced will be described.

Prof. dr. Uulke A. van der Heide (LUMC)
With integration of MRI into the radiotherapy workflow, the precision of treatment delivery has improved. MRI is now used to guide brachytherapy and with integrated MRI-linear accelerators, imaging is feasible during external beam irradiation. The challenges and potential will be discussed.

Prof. dr. Lioe-Fee de Geus-Oei (LUMC)
Nuclear medicine thrives by continuous changes. The current decade a wave of new theranostic compounds, targeting the same receptor for imaging and therapy, will change the oncology therapeutic arsenal.